Rofecoxib provides relief of pain following third molar extractions

Journal of Evidence Based Dental Practice - Tập 6 - Trang 269-270 - 2006
Paul A. Moore1
1Professor, Pharmacology and Dental Public Health Chair, Department of Anesthesiology Director, Oral Health Science Institute 552 Salk Hall School of Dental Medicine University of Pittsburgh Pittsburgh, PA 15261

Tài liệu tham khảo

Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med, 343, 1520, 10.1056/NEJM200011233432103 Cooper, 1976, A model to evaluate mild analgesics in oral surgery outpatients, Clin Pharmacol Ther, 20, 241, 10.1002/cpt1976202241 Jackson, 2000, Management of acute postoperative pain, 114 Mahmstrom, 1999, Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial, Clin Ther, 21, 1653, 10.1016/S0149-2918(99)80045-9 Morrison, 1999, Analgesic efficacy of the cyclooxygenase-2-sepcific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial, Clin Therap, 21, 943, 10.1016/S0149-2918(99)80016-2 Ehlich, 1999, Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental model, Clin Pharmacol Ther, 6, 83 Moore, 2006, Dental therapeutic practice patterns in the US. II. Analgesics, corticosteroids, and antibiotics, Gen Dent, 54, 201 Moore, 2001, Celecoxib and rofecoxib: the role of COX-2 inhibitors in dental practice, J Am Dent Assoc, 132, 451, 10.14219/jada.archive.2001.0207